C M Bidwell & Associates LTD Bristol Myers Squibb CO Transaction History

C M Bidwell & Associates LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $45,691 - $51,389	-770 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $10,681 - $12,104	-185 Reduced 19.37%	770 $48,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $4,594 - $5,091	-80 Reduced 7.73%	955 $58,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $56,738 - $66,333	1,035 New	1,035 $61,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $337,096 - $489,878	-7,265 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $357,510 - $466,340	7,265 New	7,265 $466,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $201,686 - $240,486	-4,470 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $217,957 - $282,638	4,470 New	4,470 $232,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.